Howe Jill Ann
Lineage Cell Therapeutics, Inc. · Chief Financial Officer
Howe Jill Ann is listed in public filings as officer: Chief Financial Officer. This Howe Jill Ann insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Lineage Cell Therapeutics, Inc. (LCTX). Investors use Howe Jill Ann's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $1.9M1.1M shares | Grant / ExerciseMar 5, 2026 | $1.9M1.1M shares | $1.84 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $398k750k shares | Grant / ExerciseMar 10, 2025 | $397.5K750k shares | $0.53 | -- | |
| $15k25.5k shares | BuyNov 26, 2024 | $8.8K15k shares | $0.59 | -- | |
| $9.3k10.5k shares | BuyAug 16, 2024 | $9.3K10.5k shares | $0.89 | -- |